• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞在1型糖尿病发病机制中的作用。

The role of B cells in the pathogenesis of type 1 diabetes.

作者信息

Wang Ya-Nan, Li Ruihua, Huang Yaxuan, Chen Hui, Nie Hao, Liu Lian, Zou Xiaoting, Zhong Jixin, Zheng Bing, Gong Quan

机构信息

Department of Immunology, School of Medicine, Yangtze University, Jingzhou, China.

Department of Laboratory Medicine, First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.

出版信息

Front Immunol. 2024 Dec 24;15:1450366. doi: 10.3389/fimmu.2024.1450366. eCollection 2024.

DOI:10.3389/fimmu.2024.1450366
PMID:39776900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11703732/
Abstract

Type 1 diabetes (T1D) is a metabolic disorder caused by a complete lack of insulin, primarily manifested by hyperglycemia. The mechanisms underlying the onset of T1D are complex, involving genetics, environment, and various unknown factors, leading to the infiltration of various immune components into the islets. Besides T cells, B cells are now considered important contributors to the pathogenesis of T1D, according to recent studies. In non-obese diabetic (NOD) mice, the absence of B cells prevents the development of T1D, and B-cell depletion can even restore the function of pancreatic β cells, emphasizing their involvement in the development of T1D. Naturally, besides pathogenic B cells, regulatory B cells (Bregs) might have a protective function in T1D. This article examines the mechanisms behind B-cell tolerance and the defects in B-cell tolerance checkpoints in T1D. We explored possible functions of B cells in T1D, including the role of islet autoantibodies in T1D, T-B cell interactions, and the role of Bregs in the pathogenesis of T1D. We also summarized the advances of B cell-targeted therapy, exploring new methods for intervention and treatment of T1D.

摘要

1型糖尿病(T1D)是一种由胰岛素完全缺乏引起的代谢紊乱疾病,主要表现为高血糖。T1D发病的潜在机制很复杂,涉及遗传、环境和各种未知因素,导致各种免疫成分浸润到胰岛中。根据最近的研究,除了T细胞外,B细胞现在被认为是T1D发病机制的重要促成因素。在非肥胖糖尿病(NOD)小鼠中,B细胞的缺失可阻止T1D的发展,而清除B细胞甚至可以恢复胰腺β细胞的功能,这突出了它们在T1D发展过程中的参与。自然而然地,除了致病性B细胞外,调节性B细胞(Bregs)可能在T1D中具有保护作用。本文探讨了B细胞耐受性背后的机制以及T1D中B细胞耐受性检查点的缺陷。我们探究了B细胞在T1D中的可能功能,包括胰岛自身抗体在T1D中的作用、T - B细胞相互作用以及Bregs在T1D发病机制中的作用。我们还总结了B细胞靶向治疗的进展,探索干预和治疗T1D的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/76c7a81f8721/fimmu-15-1450366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/83e6fa32b2d0/fimmu-15-1450366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/62389db4a8b8/fimmu-15-1450366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/76c7a81f8721/fimmu-15-1450366-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/83e6fa32b2d0/fimmu-15-1450366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/62389db4a8b8/fimmu-15-1450366-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7d/11703732/76c7a81f8721/fimmu-15-1450366-g003.jpg

相似文献

1
The role of B cells in the pathogenesis of type 1 diabetes.B细胞在1型糖尿病发病机制中的作用。
Front Immunol. 2024 Dec 24;15:1450366. doi: 10.3389/fimmu.2024.1450366. eCollection 2024.
2
Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.白细胞介素-10+调节性B细胞在经历抗原刺激的CD40+B细胞中产生,以维持对胰岛自身抗原的耐受性。
Diabetes. 2015 Jan;64(1):158-71. doi: 10.2337/db13-1639. Epub 2014 Sep 3.
3
Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.浆细胞增多增强了 T 细胞介导的胰岛β细胞破坏,并促进了 1 型糖尿病的发生。
Mol Med. 2022 Feb 5;28(1):18. doi: 10.1186/s10020-022-00447-y.
4
Vitamin D supplementation induces CatG-mediated CD4 T cell inactivation and restores pancreatic β-cell function in mice with type 1 diabetes.维生素 D 补充剂诱导 CatG 介导的 CD4 T 细胞失活,并恢复 1 型糖尿病小鼠的胰腺 β 细胞功能。
Am J Physiol Endocrinol Metab. 2022 Jan 1;322(1):E74-E84. doi: 10.1152/ajpendo.00066.2021. Epub 2021 Nov 15.
5
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.非肥胖糖尿病(NOD)小鼠模型在自身免疫性糖尿病中的重要性。
J Autoimmun. 2016 Jan;66:76-88. doi: 10.1016/j.jaut.2015.08.019. Epub 2015 Sep 26.
6
Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy.短暂性BAFF阻断通过富集对抗CD20联合治疗敏感的可被清除的免疫调节性B淋巴细胞,抑制非肥胖糖尿病小鼠1型糖尿病的发展。
J Immunol. 2017 Dec 1;199(11):3757-3770. doi: 10.4049/jimmunol.1700822. Epub 2017 Oct 20.
7
B cells and type 1 diabetes ...in mice and men.B细胞与1型糖尿病……在小鼠和人类中的情况
Immunol Lett. 2014 Aug;160(2):128-32. doi: 10.1016/j.imlet.2014.01.010. Epub 2014 Jan 25.
8
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.胰腺α细胞与β细胞共同促进1型糖尿病中CXCL10的表达。
Front Endocrinol (Lausanne). 2020 Sep 15;11:630. doi: 10.3389/fendo.2020.00630. eCollection 2020.
9
IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.白细胞介素-2免疫疗法揭示了在自身免疫性糖尿病的非肥胖糖尿病小鼠模型中,天然β细胞再生的潜力。
PLoS One. 2013 Oct 24;8(10):e78483. doi: 10.1371/journal.pone.0078483. eCollection 2013.
10
Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.胰腺十二指肠同源盒蛋白 1 是 1 型糖尿病的一种新型胰岛β细胞特异性自身抗原。
Lab Invest. 2010 Jan;90(1):31-9. doi: 10.1038/labinvest.2009.116. Epub 2009 Nov 9.

引用本文的文献

1
Measuring Human Memory B Cells in Autoimmunity Using Enzyme-Linked ImmunoSpot.使用酶联免疫斑点法检测自身免疫中的人类记忆B细胞。
Biomolecules. 2025 Apr 30;15(5):643. doi: 10.3390/biom15050643.
2
The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus.调节性B细胞在抑制人类炎症性疾病中的免疫耐受作用,重点关注糖尿病。
Front Immunol. 2025 Apr 30;16:1565158. doi: 10.3389/fimmu.2025.1565158. eCollection 2025.
3
Tissue Resident and Infiltrating Immune Cells: Their Influence on the Demise of Beta Cells in Type 1 Diabetes.

本文引用的文献

1
Distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies.不同首发自身抗体的 1 型糖尿病患儿存在不同的细胞免疫应答。
Nat Commun. 2024 May 7;15(1):3810. doi: 10.1038/s41467-024-47918-w.
2
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration.程序性死亡受体1(PD-1)阳性T细胞通过改善调节性T细胞的抑制活性,与调节性T细胞和利妥昔单抗联合治疗1型糖尿病儿童的疗效相关。
Int Immunopharmacol. 2024 May 10;132:111919. doi: 10.1016/j.intimp.2024.111919. Epub 2024 Mar 30.
3
组织驻留和浸润性免疫细胞:它们对1型糖尿病中β细胞死亡的影响
Biomolecules. 2025 Mar 19;15(3):441. doi: 10.3390/biom15030441.
Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
Fcrl5 上调会破坏 B 细胞失能,并导致自身免疫性疾病。
Front Immunol. 2023 Sep 28;14:1276014. doi: 10.3389/fimmu.2023.1276014. eCollection 2023.
4
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice.新型工程化 B 淋巴细胞靶向胰岛特异性 T 细胞可抑制非肥胖型糖尿病重症联合免疫缺陷小鼠 1 型糖尿病的发展。
Front Immunol. 2023 Sep 4;14:1227133. doi: 10.3389/fimmu.2023.1227133. eCollection 2023.
5
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.与胰岛自身抗体人群中曲线下血糖和 C 肽面积定义区域相关的表型。
Diabetes Care. 2023 May 1;46(5):1098-1105. doi: 10.2337/dc22-2236.
6
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.CARD19,一种自身反应性 B 细胞中 TAK1/NF-κB 通路的新型调节因子。
J Immunol. 2023 May 1;210(9):1222-1235. doi: 10.4049/jimmunol.2200639.
7
Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice.1 型糖尿病易感和抗性小鼠胰岛素反应性 B 细胞库的比较分析。
Front Immunol. 2022 Oct 4;13:961209. doi: 10.3389/fimmu.2022.961209. eCollection 2022.
8
Combined therapy with CD4 CD25highCD127 T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial.联合应用 CD4 CD25highCD127 T 调节细胞和抗 CD20 抗体治疗近期发病 1 型糖尿病优于单药治疗:随机 I/II 期试验。
Diabetes Obes Metab. 2022 Aug;24(8):1534-1543. doi: 10.1111/dom.14723. Epub 2022 May 9.
9
Dynamic Number and Function of IL-10-Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 Diabetes.1 型糖尿病不同阶段免疫微环境中 IL-10 产生调节性 B 细胞的动态数量和功能。
J Immunol. 2022 Mar 1;208(5):1034-1041. doi: 10.4049/jimmunol.2100357. Epub 2022 Feb 9.
10
Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.浆细胞增多增强了 T 细胞介导的胰岛β细胞破坏,并促进了 1 型糖尿病的发生。
Mol Med. 2022 Feb 5;28(1):18. doi: 10.1186/s10020-022-00447-y.